143 related articles for article (PubMed ID: 2857061)
21. Diuretics, serum potassium and ventricular arrhythmias in the Multiple Risk Factor Intervention Trial.
Cohen JD; Neaton JD; Prineas RJ; Daniels KA
Am J Cardiol; 1987 Sep; 60(7):548-54. PubMed ID: 2442992
[TBL] [Abstract][Full Text] [Related]
22. Coronary heart disease morbidity and mortality in hypercholesterolemic men predicted from an exercise test: the Lipid Research Clinics Coronary Primary Prevention Trial.
Ekelund LG; Suchindran CM; McMahon RP; Heiss G; Leon AS; Romhilt DW; Rubenstein CL; Probstfield JL; Ruwitch JF
J Am Coll Cardiol; 1989 Sep; 14(3):556-63. PubMed ID: 2768706
[TBL] [Abstract][Full Text] [Related]
23. Multiple risk factor intervention trial revisited: a new perspective based on nonfatal and fatal composite endpoints, coronary and cardiovascular, during the trial.
Stamler J; Neaton JD; Cohen JD; Cutler J; Eberly L; Grandits G; Kuller LH; Ockene J; Prineas R;
J Am Heart Assoc; 2012 Oct; 1(5):e003640. PubMed ID: 23316301
[TBL] [Abstract][Full Text] [Related]
24. The effect of antihypertensive drug treatment on mortality in the presence of resting electrocardiographic abnormalities at baseline: the HDFP experience. The Hypertension Detection and Follow-up Program Cooperative Research Group.
Circulation; 1984 Dec; 70(6):996-1003. PubMed ID: 6388901
[TBL] [Abstract][Full Text] [Related]
25. Heart rate adjustment of ST-segment depression for reduction of false positive electrocardiographic responses to exercise in asymptomatic men screened for coronary artery disease.
Okin PM; Kligfield P; Milner MR; Goldstein SA; Lindsay J
Am J Cardiol; 1988 Nov; 62(16):1043-7. PubMed ID: 3189166
[TBL] [Abstract][Full Text] [Related]
26. The drug treatment of mild hypertension in the Multiple Risk Factor Intervention Trial. A review.
Grimm RH
Drugs; 1986; 31 Suppl 1():13-21. PubMed ID: 3720569
[TBL] [Abstract][Full Text] [Related]
27. Cigarette smoking and mortality. MRFIT Research Group.
Kuller LH; Ockene JK; Meilahn E; Wentworth DN; Svendsen KH; Neaton JD
Prev Med; 1991 Sep; 20(5):638-54. PubMed ID: 1758843
[TBL] [Abstract][Full Text] [Related]
28. Comparison of smoking behavior change for SI and UC study groups. MRFIT Research Group.
Ockene JK; Hymowitz N; Lagus J; Shaten BJ
Prev Med; 1991 Sep; 20(5):564-73. PubMed ID: 1758838
[TBL] [Abstract][Full Text] [Related]
29. Blood pressure at health screening as a predictor of coronary heart disease in Kyoto.
Sasaki S; Nakamura K; Uchida A; Fujita H; Itoh H; Nakata T; Takeda K; Nakagawa M
J Cardiovasc Risk; 1996 Feb; 3(1):77-82. PubMed ID: 8783034
[TBL] [Abstract][Full Text] [Related]
30. Incidence of type 2 diabetes in the randomized multiple risk factor intervention trial.
Davey Smith G; Bracha Y; Svendsen KH; Neaton JD; Haffner SM; Kuller LH;
Ann Intern Med; 2005 Mar; 142(5):313-22. PubMed ID: 15738450
[TBL] [Abstract][Full Text] [Related]
31. The psychological effects of differential treatment of a high risk sample in a randomized clinical trial.
Benfari RC; McIntyre K; Eaker E; Blumberg S; Paul O
Am J Public Health; 1979 Oct; 69(10):996-1000. PubMed ID: 484765
[TBL] [Abstract][Full Text] [Related]
32. Relationship of baseline major risk factors to coronary and all-cause mortality, and to longevity: findings from long-term follow-up of Chicago cohorts.
Stamler J; Dyer AR; Shekelle RB; Neaton J; Stamler R
Cardiology; 1993; 82(2-3):191-222. PubMed ID: 8324780
[TBL] [Abstract][Full Text] [Related]
33. Sensitivity of exercise electrocardiography for acute cardiac events during moderate and strenuous physical activity. The Lipid Research Clinics Coronary Primary Prevention Trial.
Siscovick DS; Ekelund LG; Johnson JL; Truong Y; Adler A
Arch Intern Med; 1991 Feb; 151(2):325-30. PubMed ID: 1992960
[TBL] [Abstract][Full Text] [Related]
34. The effect of "usual care" on cardiovascular risk factors in a clinical trial.
Luepker RV; Grimm RH; Taylor HL
Control Clin Trials; 1984 Mar; 5(1):47-53. PubMed ID: 6713907
[TBL] [Abstract][Full Text] [Related]
35. Dietary intake in the Multiple Risk Factor Intervention Trial (MRFIT): nutrient and food group changes over 6 years.
Gorder DD; Dolecek TA; Coleman GG; Tillotson JL; Brown HB; Lenz-Litzow K; Bartsch GE; Grandits G
J Am Diet Assoc; 1986 Jun; 86(6):744-51. PubMed ID: 3519736
[TBL] [Abstract][Full Text] [Related]
36. The epidemiology of pulmonary function and COPD mortality in the multiple risk factor intervention trial.
Kuller LH; Ockene JK; Townsend M; Browner W; Meilahn E; Wentworth DN
Am Rev Respir Dis; 1989 Sep; 140(3 Pt 2):S76-81. PubMed ID: 2782764
[TBL] [Abstract][Full Text] [Related]
37. Serum cholesterol, blood pressure, cigarette smoking, and death from coronary heart disease. Overall findings and differences by age for 316,099 white men. Multiple Risk Factor Intervention Trial Research Group.
Neaton JD; Wentworth D
Arch Intern Med; 1992 Jan; 152(1):56-64. PubMed ID: 1728930
[TBL] [Abstract][Full Text] [Related]
38. Special intervention reduces CVD mortality for adherent participants in the multiple risk factor intervention trial.
Gump BB; Matthews KA
Ann Behav Med; 2003 Aug; 26(1):61-8. PubMed ID: 12867355
[TBL] [Abstract][Full Text] [Related]
39. Oslo Study Diet and Antismoking Trial. Results after 102 months.
Hjermann I; Holme I; Leren P
Am J Med; 1986 Feb; 80(2A):7-11. PubMed ID: 3511692
[TBL] [Abstract][Full Text] [Related]
40. A long-term nutrition intervention experience: lipid responses and dietary adherence patterns in the Multiple Risk Factor Intervention Trial.
Dolecek TA; Milas NC; Van Horn LV; Farrand ME; Gorder DD; Duchene AG; Dyer JR; Stone PA; Randall BL
J Am Diet Assoc; 1986 Jun; 86(6):752-8. PubMed ID: 3519737
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
